Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma

doi:10.3748/wjg.v21.i13.3928

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8894)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

706

WORD

209

HTML

5137

Figures (1-2)

211

Tables (1-3)

202

Sum=6465

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1184

Download

1245

Sum=2429

Apr 7, 2015 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (64)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 7, 2015; 21(13): 3928-3935
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3928

Open in New Tab Full Size Figure Download Figure

Figure 1 Receiver operating characteristic curves comparing prothrombin induced by vitamin K absence-II, alpha-fetoprotein and a combination of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in patients with hepatocellular carcinoma vs those with nonmalignant chronic hepatitis B. The AUROC curves for PIVKA-II, AFP, and Combination are indicated in the inset. P = 0.965 for AFP vs PIVKA-II, P < 0.001 for combination vs PIVKA-II and P = 0.037 for combination vs AFP. PIVKA-II: Prothrombin induced by vitamin K absence-II; HCC: Hepatocellular carcinoma; AFP: Alpha-fetoprotein.

Open in New Tab Full Size Figure Download Figure

Figure 2 Receiver operating characteristic curves comparing prothrombin induced by vitamin K absence-II, alpha-fetoprotein and a combination of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in patients with hepatocellular carcinoma vs those with liver cirrhosis. The AUROC curves for PIVKA-II, AFP, and Combination are indicated in the inset. P = 0.042 for AFP vs PIVKA-II, P = 0.001 for combination vs PIVKA-II and P < 0.001 for combination vs AFP. PIVKA-II: Prothrombin induced by vitamin K absence-II; HCC: Hepatocellular carcinoma; AFP: Alpha-fetoprotein.

Citation: Seo SI, Kim HS, Kim WJ, Shin WG, Kim DJ, Kim KH, Jang MK, Lee JH, Kim JS, Kim HY, Kim DJ, Lee MS, Park CK. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3928-3935
URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3928.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3928